Navigation Links
Oppenheimer Announces the Addition of Several Recent Senior Hires in Investment Banking
Date:3/17/2009

NEW YORK, March 17 /PRNewswire/ -- Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings Inc., is pleased to announce the addition of several recent senior hires in the Investment Banking Department.

Brian A. McCarthy has joined the firm as the Head of our Healthcare Investment Banking Group. Brian has more than 20 years of investment banking experience and most recently served as Co-head of Global Healthcare at JPMorgan. Prior to JPM, Brian spent seven years at Lehman Brothers where he was also Co-head of Healthcare. Brian has extensive experience in multiple healthcare subsectors and a proven track record of serving as a trusted advisor to his clients. Brian will report to Marshall A. Heinberg, Senior Managing Director and Head of Investment Banking at Oppenheimer.

Joining Brian as a Managing Director in Healthcare is Jaime Burnes. Jaime most recently was a member of the Healthcare Group at Credit Suisse. Jaime had been with Credit Suisse since 2006, generating and executing financing and M&A transactions in the biotechnology and specialty pharmaceutical sectors. Prior to working at Credit Suisse, Jaime worked for Lehman Brothers. At Oppenheimer, Jaime will continue his focus on the life sciences space.

Also joining the firm as a Director in Healthcare is Eric Rabinowitz. Eric joins Oppenheimer from JPMorgan (and before that Bear Stearns) where he was a Vice President in the Healthcare Group. Eric had been with Bear Stearns since 2003 advising clients and executing transactions across multiple healthcare subsectors. At Oppenheimer, Eric will focus on the healthcare services space.

David Sommer has joined our Financial Sponsors Group as a Managing Director. David has approximately fifteen years of investment banking experience and most recently was a Managing Director in the Financial Sponsor Group at JPMorgan. Prior to JPM, David spent nine years at CIBC World Markets Corp. where he was a Managing Director in the Financial Sponsor/Leveraged Finance Group. David has also worked in the Leveraged Finance Group at JPMorgan and at the General Electric Company in Corporate Business Development. David has a proven track record of generating equity, M&A, and leveraged finance business with financial sponsors and their portfolio companies.

Jeffrey Berson has joined our Technology and Telecom Group as a Managing Director. Jeff joins us from Barclays Capital where he was a Managing Director in the Telecom Group. Jeff had been with Barclays since 2007 focusing on the Wireline, Wireless and Emerging Telecom sectors. Prior to working at Barclays, Jeff worked for CIBC World Markets in the Technology & Telecom Group. At Oppenheimer, Jeff will continue his coverage of growth companies in both the wireline and wireless sectors.

"We are delighted to be able to recruit such an outstanding roster of high quality professionals to our firm," noted Marshall Heinberg. "Each of these individuals are proven bankers who are well positioned to serve their clients at Oppenheimer. We have witnessed a tremendous opportunity to recruit seasoned bankers who are well versed in delivering a full suite of banking products to our middle market clients."

Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Certain statements in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Oppenheimer & Co. Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
2. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
3. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
6. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
7. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
8. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
9. AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference
10. Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):